View More Recent Stories

Oct 29, 2018 07:30AM Marinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial Results
Oct 10, 2018 07:30AM Marinus Pharmaceuticals Names Dr. Rolando Gutíerrez-Esteinou as VP of Clinical Development and Pharmacovigilance
Oct 9, 2018 04:48PM Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
Oct 5, 2018 04:00PM Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sep 25, 2018 07:32AM Marinus Pharma (MRNS) Reports Complete Enrollment for Magnolia Postpartum Depression Study
Sep 25, 2018 07:30AM Marinus Completes Enrollment in its Magnolia Postpartum Depression Study
Sep 20, 2018 04:05PM Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sep 5, 2018 07:33AM Marinus Pharma (MRNS) Announces Scott Braunstein MD to Board
Sep 5, 2018 07:30AM Marinus Appoints Scott Braunstein, MD to its Board of Directors
Aug 30, 2018 04:15PM Marinus Pharmaceuticals to Present at the Baird Healthcare Conference
Aug 7, 2018 07:30AM Marinus Pharmaceuticals to Present at Wedbush/PacGrow Healthcare Conference
Aug 2, 2018 07:30AM Marinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial Results
Jul 30, 2018 04:05PM Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun 21, 2018 07:30AM Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index
Jun 19, 2018 07:31AM Marinus Pharma (MRNS) Commences Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder
Jun 19, 2018 07:30AM Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder
Jun 15, 2018 04:05PM Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
May 30, 2018 07:30AM Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
May 14, 2018 07:30AM Marinus Pharmaceuticals to Present at the UBS Global Healthcare Conference
May 2, 2018 07:30AM Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results
Mar 8, 2018 07:30AM Marinus Pharmaceuticals to Present at the Barclays Global Healthcare Conference
Mar 6, 2018 07:30AM Marinus Pharmaceuticals Provides Business Update and 2017 Financial Results
Feb 7, 2018 07:30AM Marinus Pharmaceuticals to Attend Upcoming Investor Conferences
Dec 13, 2017 07:30AM Marinus Pharmaceuticals Added to NASDAQ Biotechnology Index
Oct 31, 2017 07:30AM Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2017 Financial Results
Sep 21, 2017 04:01PM Marinus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 11, 2017 07:31AM Marinus Pharma (MRNS) Reports Successful Clinical Trial Results from Phase 2 Study in Patients with CDKL5 Disorder
Sep 11, 2017 07:30AM Marinus Announces Successful Clinical Trial Results and Declares CDKL5 Disorder Its Lead Pediatric Orphan Epilepsy Program for Ganaxolone
Aug 1, 2017 07:30AM Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2017 Financial Results
Jun 29, 2017 02:29PM Marinus Pharma (MRNS) Says FDA Grants Orphan Drug Designation for Ganaxolone in CDKL5 Disorder
Jun 29, 2017 02:29PM FDA Grants Orphan Drug Designation for Ganaxolone in CDKL5 Disorder
Jun 27, 2017 07:34AM Marinus Pharma (MRNS) Launches Ganaxolone Clinical Program in Patients with PPD
Jun 27, 2017 07:30AM Marinus Pharmaceuticals Launches the Ganaxolone Clinical Program in Patients with Postpartum Depression
May 1, 2017 07:30AM Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2017 Financial Results
Apr 18, 2017 07:35AM Marinus Pharma (MRNS) to Present Ganaxolone DATA at AAN
Apr 18, 2017 07:30AM Marinus to present Ganaxolone DATA at American academy of neurology annual meeting
Apr 5, 2017 09:03AM Ligand Pharma (LGND) Announces Commercial License and Supply Agreements with Marinus Pharmaceuticals (MRNS) for Captisol-Enabled Ganaxolone
Apr 5, 2017 09:00AM Ligand Enters Commercial License and Supply Agreements with Marinus Pharmaceuticals for Captisol-Enabled Ganaxolone
View More Recent Stories